vs
Side-by-side financial comparison of Avery Dennison (AVY) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Avery Dennison is the larger business by last-quarter revenue ($2.3B vs $1.3B, roughly 1.7× HAEMONETICS CORP). Avery Dennison runs the higher net margin — 7.3% vs 7.3%, a 0.0% gap on every dollar of revenue. On growth, Avery Dennison posted the faster year-over-year revenue change (7.0% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $104.4M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 1.4%).
Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AVY vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.3B |
| Net Profit | $168.1M | $97.3M |
| Gross Margin | 28.9% | 14.9% |
| Operating Margin | 10.7% | 83.4% |
| Net Margin | 7.3% | 7.3% |
| Revenue YoY | 7.0% | 4.8% |
| Net Profit YoY | 1.1% | -42.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.3B | $1.3B | ||
| Q4 25 | $2.3B | $339.0M | ||
| Q3 25 | $2.2B | $327.3M | ||
| Q2 25 | $2.2B | $321.4M | ||
| Q1 25 | $2.1B | $330.6M | ||
| Q4 24 | $2.2B | $348.5M | ||
| Q3 24 | $2.2B | $345.5M | ||
| Q2 24 | $2.2B | $336.2M |
| Q1 26 | $168.1M | $97.3M | ||
| Q4 25 | $166.4M | $44.7M | ||
| Q3 25 | $166.3M | $38.7M | ||
| Q2 25 | $189.0M | $34.0M | ||
| Q1 25 | $166.3M | $58.0M | ||
| Q4 24 | $174.0M | $37.5M | ||
| Q3 24 | $181.7M | $33.8M | ||
| Q2 24 | $176.8M | $38.4M |
| Q1 26 | 28.9% | 14.9% | ||
| Q4 25 | 28.7% | 59.7% | ||
| Q3 25 | 28.7% | 59.5% | ||
| Q2 25 | 28.8% | 59.8% | ||
| Q1 25 | 28.9% | 58.4% | ||
| Q4 24 | 27.9% | 55.5% | ||
| Q3 24 | 28.7% | 54.2% | ||
| Q2 24 | 29.6% | 52.0% |
| Q1 26 | 10.7% | 83.4% | ||
| Q4 25 | 9.1% | 19.9% | ||
| Q3 25 | 10.6% | 17.9% | ||
| Q2 25 | 11.5% | 16.8% | ||
| Q1 25 | 10.6% | 21.6% | ||
| Q4 24 | 11.0% | 16.9% | ||
| Q3 24 | 11.0% | 15.0% | ||
| Q2 24 | 10.7% | 11.8% |
| Q1 26 | 7.3% | 7.3% | ||
| Q4 25 | 7.3% | 13.2% | ||
| Q3 25 | 7.5% | 11.8% | ||
| Q2 25 | 8.5% | 10.6% | ||
| Q1 25 | 7.7% | 17.5% | ||
| Q4 24 | 8.0% | 10.8% | ||
| Q3 24 | 8.3% | 9.8% | ||
| Q2 24 | 7.9% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $2.16 | $0.95 | ||
| Q3 25 | $2.13 | $0.81 | ||
| Q2 25 | $2.41 | $0.70 | ||
| Q1 25 | $2.09 | $1.17 | ||
| Q4 24 | $2.17 | $0.74 | ||
| Q3 24 | $2.25 | $0.66 | ||
| Q2 24 | $2.18 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.1M | $245.4M |
| Total DebtLower is stronger | $3.2B | $1.2B |
| Stockholders' EquityBook value | $2.3B | $796.3M |
| Total Assets | $9.0B | $2.4B |
| Debt / EquityLower = less leverage | 1.38× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $255.1M | $245.4M | ||
| Q4 25 | $202.8M | $363.4M | ||
| Q3 25 | $536.3M | $296.4M | ||
| Q2 25 | $215.9M | $292.9M | ||
| Q1 25 | $195.9M | $306.8M | ||
| Q4 24 | $329.1M | $320.8M | ||
| Q3 24 | $212.7M | $299.3M | ||
| Q2 24 | $208.8M | $344.4M |
| Q1 26 | $3.2B | $1.2B | ||
| Q4 25 | $3.2B | $1.2B | ||
| Q3 25 | $3.2B | $1.2B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.6B | $1.2B | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.0B | — |
| Q1 26 | $2.3B | $796.3M | ||
| Q4 25 | $2.2B | $911.5M | ||
| Q3 25 | $2.2B | $849.2M | ||
| Q2 25 | $2.2B | $882.3M | ||
| Q1 25 | $2.2B | $820.8M | ||
| Q4 24 | $2.3B | $906.9M | ||
| Q3 24 | $2.4B | $878.9M | ||
| Q2 24 | $2.3B | $905.4M |
| Q1 26 | $9.0B | $2.4B | ||
| Q4 25 | $8.8B | $2.5B | ||
| Q3 25 | $8.9B | $2.4B | ||
| Q2 25 | $8.6B | $2.5B | ||
| Q1 25 | $8.4B | $2.5B | ||
| Q4 24 | $8.4B | $2.5B | ||
| Q3 24 | $8.5B | $2.5B | ||
| Q2 24 | $8.3B | $2.5B |
| Q1 26 | 1.38× | 1.53× | ||
| Q4 25 | 1.43× | 1.34× | ||
| Q3 25 | 1.45× | 1.44× | ||
| Q2 25 | 1.19× | 1.39× | ||
| Q1 25 | 1.19× | 1.49× | ||
| Q4 24 | 1.11× | — | ||
| Q3 24 | 0.85× | — | ||
| Q2 24 | 0.89× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | $104.4M | $209.9M |
| FCF MarginFCF / Revenue | 4.5% | 15.7% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $869.1M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $376.8M | $93.6M | ||
| Q3 25 | $312.1M | $111.3M | ||
| Q2 25 | $208.8M | $17.4M | ||
| Q1 25 | $-16.3M | $116.6M | ||
| Q4 24 | $351.2M | $43.8M | ||
| Q3 24 | $270.1M | $48.8M | ||
| Q2 24 | $197.7M | $-27.4M |
| Q1 26 | $104.4M | $209.9M | ||
| Q4 25 | $309.7M | $87.2M | ||
| Q3 25 | $276.2M | $106.3M | ||
| Q2 25 | $178.8M | $13.6M | ||
| Q1 25 | $-52.3M | $100.9M | ||
| Q4 24 | $281.7M | $35.2M | ||
| Q3 24 | $227.1M | $39.4M | ||
| Q2 24 | $150.2M | $-33.1M |
| Q1 26 | 4.5% | 15.7% | ||
| Q4 25 | 13.6% | 25.7% | ||
| Q3 25 | 12.5% | 32.5% | ||
| Q2 25 | 8.1% | 4.2% | ||
| Q1 25 | -2.4% | 30.5% | ||
| Q4 24 | 12.9% | 10.1% | ||
| Q3 24 | 10.4% | 11.4% | ||
| Q2 24 | 6.7% | -9.8% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 3.0% | 1.9% | ||
| Q3 25 | 1.6% | 1.5% | ||
| Q2 25 | 1.4% | 1.2% | ||
| Q1 25 | 1.7% | 4.7% | ||
| Q4 24 | 3.2% | 2.5% | ||
| Q3 24 | 2.0% | 2.7% | ||
| Q2 24 | 2.1% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 2.26× | 2.09× | ||
| Q3 25 | 1.88× | 2.88× | ||
| Q2 25 | 1.10× | 0.51× | ||
| Q1 25 | -0.10× | 2.01× | ||
| Q4 24 | 2.02× | 1.17× | ||
| Q3 24 | 1.49× | 1.44× | ||
| Q2 24 | 1.12× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVY
| Materials Group | $1.6B | 72% |
| Solutions Group | $649.2M | 28% |
HAE
Segment breakdown not available.
